The Impact of Breast Surgery on Patients' Quality of Life

December 2, 2025 updated by: University Hospital, Basel, Switzerland
The investigators aim to document the surgery-specific and overall Quality of life parameters of patients undergoing all types of breast surgery at the University Hospital of Basel

Study Overview

Status

Recruiting

Conditions

Detailed Description

The planned ten-year follow-up using Patient reported outcome measure will give us the unique opportunity to gain insight into patients' breast-related QoL (Quality of Life) long after surgery and detect systematic issues that may affect them beyond the scope of routine follow-up consultations. Along with the detection of any occurring adverse events, the information gathered in the database will facilitate the search for risk factors involved in their development, ideally resulting in their rectification and thus contributing to patient well-being in the long term.

Study Type

Observational

Enrollment (Estimated)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Basel, Switzerland, 4031
        • Recruiting
        • University Hospital Basel
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

patients who underwent breast surgery at the University Hospital Basel from 2014 onwards

Description

Inclusion Criteria:

  • adults who underwent any type of breast surgery at the University Hospital of Basel

Exclusion Criteria:

  • Patients under the age of 18 years, without general consent or written informed consent, with insufficient language comprehension or other factors limiting their ability to co-operate in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient satisfaction
Time Frame: up to 10 years
five point likert-scale for satisfaction ( psychometric survey response scale ranging from "Strongly Disagree" to "Strongly Agree". The format includes: 1. Strongly Disagree, 2. Disagree, 3. Neutral (or Neither Agree nor Disagree), 4. Agree, and 5. Strongly Agree Descriptive measures using patient-reported outcome measures (BREAST-Q, McGill short form, EQ-5D-5L)
up to 10 years
Patient reported quality of life
Time Frame: up to 10 years
Descriptive measures using patient-reported outcome measures (BREAST-Q, McGill short form, EQ-5D-5L)
up to 10 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Elisabeth Kappos, Prof., University Hospital, Basel, Switzerland

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 16, 2025

Primary Completion (Estimated)

June 30, 2035

Study Completion (Estimated)

June 30, 2035

Study Registration Dates

First Submitted

December 2, 2025

First Submitted That Met QC Criteria

December 2, 2025

First Posted (Actual)

December 15, 2025

Study Record Updates

Last Update Posted (Actual)

December 15, 2025

Last Update Submitted That Met QC Criteria

December 2, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 2025-00210; bb25kappos3

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breast Surgery

Subscribe